Microbot Medical Inc. (NASDAQ: MBOT) Stock Competitors & Peer Comparison
See MBOT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MBOT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MBOT | $1.55 | -7.74% | 70.6M | -5.96 | -$0.26 | N/A |
| ISRG | $394.51 | -1.68% | 139.4B | 41.01 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.04% |
| BDX | $183.40 | +0.79% | 50.5B | 14.11 | $13.00 | +2.04% |
| MDLN | $35.74 | +0.45% | 30.2B | 26.19 | $1.36 | N/A |
| WST | $349.42 | +0.94% | 24.6B | 43.83 | $7.97 | +0.25% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $88.59 | +2.46% | 15.3B | 12.48 | $7.10 | N/A |
| COO | $76.17 | -0.56% | 14.9B | 16.70 | $4.56 | N/A |
| BAX | $26.73 | -1.18% | 13.8B | 12.85 | $2.08 | +0.75% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
MBOT vs ISRG Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ISRG has a market cap of 139.4B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ISRG trades at $394.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ISRG's P/E ratio is 41.01. In terms of profitability, MBOT's ROE is -0.22%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, MBOT is more volatile compared to ISRG. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
MBOT vs BDXA Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas BDXA's P/E ratio is 45.70. In terms of profitability, MBOT's ROE is -0.22%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, MBOT is more volatile compared to BDXA. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
MBOT vs BDX Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, BDX has a market cap of 50.5B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while BDX trades at $183.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas BDX's P/E ratio is 14.11. In terms of profitability, MBOT's ROE is -0.22%, compared to BDX's ROE of +0.04%. Regarding short-term risk, MBOT is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check BDX's competition here
Medline Inc. (NASDAQ: MDLN)
MBOT vs MDLN Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, MDLN has a market cap of 30.2B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while MDLN trades at $35.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas MDLN's P/E ratio is 26.19. In terms of profitability, MBOT's ROE is -0.22%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, MBOT is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
MBOT vs WST Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, WST has a market cap of 24.6B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while WST trades at $349.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas WST's P/E ratio is 43.83. In terms of profitability, MBOT's ROE is -0.22%, compared to WST's ROE of +0.19%. Regarding short-term risk, MBOT is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
MBOT vs HOLX Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas HOLX's P/E ratio is 31.54. In terms of profitability, MBOT's ROE is -0.22%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, MBOT is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
MBOT vs SOLV Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, SOLV has a market cap of 15.3B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while SOLV trades at $88.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas SOLV's P/E ratio is 12.48. In terms of profitability, MBOT's ROE is -0.22%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, MBOT is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check SOLV's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
MBOT vs COO Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, COO has a market cap of 14.9B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while COO trades at $76.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas COO's P/E ratio is 16.70. In terms of profitability, MBOT's ROE is -0.22%, compared to COO's ROE of +0.03%. Regarding short-term risk, MBOT is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check COO's competition here
Baxter International Inc. (NYSE: BAX)
MBOT vs BAX Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, BAX has a market cap of 13.8B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while BAX trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas BAX's P/E ratio is 12.85. In terms of profitability, MBOT's ROE is -0.22%, compared to BAX's ROE of -0.17%. Regarding short-term risk, MBOT is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check BAX's competition here
Becton, Dickinson and Company (NYSE: BDXB)
MBOT vs BDXB Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas BDXB's P/E ratio is 7.60. In terms of profitability, MBOT's ROE is -0.22%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, MBOT is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check BDXB's competition here
Repligen Corporation (NASDAQ: RGEN)
MBOT vs RGEN Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, RGEN has a market cap of 9.4B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while RGEN trades at $166.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas RGEN's P/E ratio is 92.68. In terms of profitability, MBOT's ROE is -0.22%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, MBOT is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
MBOT vs AVTR Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, AVTR has a market cap of 9.2B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while AVTR trades at $13.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas AVTR's P/E ratio is 16.07. In terms of profitability, MBOT's ROE is -0.22%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, MBOT is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
MBOT vs ATR Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ATR trades at $132.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ATR's P/E ratio is 23.09. In terms of profitability, MBOT's ROE is -0.22%, compared to ATR's ROE of +0.14%. Regarding short-term risk, MBOT is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
MBOT vs BLCO Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, BLCO has a market cap of 6.1B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while BLCO trades at $17.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas BLCO's P/E ratio is 26.20. In terms of profitability, MBOT's ROE is -0.22%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, MBOT is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check BLCO's competition here
Teleflex Incorporated (NYSE: TFX)
MBOT vs TFX Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, TFX has a market cap of 6.1B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while TFX trades at $137.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas TFX's P/E ratio is 15.67. In terms of profitability, MBOT's ROE is -0.22%, compared to TFX's ROE of -0.32%. Regarding short-term risk, MBOT is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check TFX's competition here
Stevanato Group S.p.A. (NYSE: STVN)
MBOT vs STVN Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, STVN has a market cap of 5.8B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while STVN trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas STVN's P/E ratio is 32.01. In terms of profitability, MBOT's ROE is -0.22%, compared to STVN's ROE of +0.09%. Regarding short-term risk, MBOT is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
MBOT vs MMSI Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, MMSI has a market cap of 5.4B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while MMSI trades at $90.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas MMSI's P/E ratio is 23.21. In terms of profitability, MBOT's ROE is -0.22%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, MBOT is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
MBOT vs ICUI Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ICUI has a market cap of 4.6B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ICUI trades at $182.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ICUI's P/E ratio is 22.84. In terms of profitability, MBOT's ROE is -0.22%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, MBOT is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
MBOT vs NVST Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, NVST has a market cap of 4.6B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while NVST trades at $28.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas NVST's P/E ratio is 19.10. In terms of profitability, MBOT's ROE is -0.22%, compared to NVST's ROE of +0.04%. Regarding short-term risk, MBOT is more volatile compared to NVST. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
MBOT vs PLSE Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, PLSE has a market cap of 3.1B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while PLSE trades at $44.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas PLSE's P/E ratio is -37.75. In terms of profitability, MBOT's ROE is -0.22%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, MBOT is more volatile compared to PLSE. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check PLSE's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
MBOT vs XRAY Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, XRAY has a market cap of 2.3B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while XRAY trades at $11.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas XRAY's P/E ratio is 8.10. In terms of profitability, MBOT's ROE is -0.22%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, MBOT is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check XRAY's competition here
AtriCure, Inc. (NASDAQ: ATRC)
MBOT vs ATRC Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ATRC has a market cap of 2.3B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ATRC trades at $44.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ATRC's P/E ratio is 1375.78. In terms of profitability, MBOT's ROE is -0.22%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, MBOT is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ATRC's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
MBOT vs LMAT Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while LMAT trades at $82.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas LMAT's P/E ratio is 30.29. In terms of profitability, MBOT's ROE is -0.22%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, MBOT is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
MBOT vs BLFS Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, BLFS has a market cap of 1.7B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while BLFS trades at $35.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas BLFS's P/E ratio is -165.93. In terms of profitability, MBOT's ROE is -0.22%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, MBOT is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check BLFS's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
MBOT vs KMTS Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, KMTS has a market cap of 1.6B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while KMTS trades at $28.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas KMTS's P/E ratio is -11.87. In terms of profitability, MBOT's ROE is -0.22%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, MBOT is more volatile compared to KMTS. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check KMTS's competition here
Azenta, Inc. (NASDAQ: AZTA)
MBOT vs AZTA Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while AZTA trades at $33.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas AZTA's P/E ratio is 79.48. In terms of profitability, MBOT's ROE is -0.22%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, MBOT is more volatile compared to AZTA. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check AZTA's competition here
STAAR Surgical Company (NASDAQ: STAA)
MBOT vs STAA Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, STAA has a market cap of 1.3B. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while STAA trades at $26.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas STAA's P/E ratio is 45.93. In terms of profitability, MBOT's ROE is -0.22%, compared to STAA's ROE of +0.01%. Regarding short-term risk, MBOT is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
MBOT vs QDEL Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, QDEL has a market cap of 975.1M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while QDEL trades at $14.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas QDEL's P/E ratio is 10.67. In terms of profitability, MBOT's ROE is -0.22%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, MBOT is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
MBOT vs ATRI Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ATRI's P/E ratio is 64.50. In terms of profitability, MBOT's ROE is -0.22%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, MBOT is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
MBOT vs ANGO Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ANGO has a market cap of 655.1M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ANGO trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ANGO's P/E ratio is -40.64. In terms of profitability, MBOT's ROE is -0.22%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, MBOT is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
MBOT vs NNNN Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, NNNN has a market cap of 381.9M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while NNNN trades at $8.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas NNNN's P/E ratio is 125.72. In terms of profitability, MBOT's ROE is -0.22%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, MBOT is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check NNNN's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
MBOT vs SMTI Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, SMTI has a market cap of 313.9M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while SMTI trades at $34.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas SMTI's P/E ratio is -569.17. In terms of profitability, MBOT's ROE is -0.22%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, MBOT is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
MBOT vs OSUR Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, OSUR has a market cap of 264.4M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while OSUR trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas OSUR's P/E ratio is -6.98. In terms of profitability, MBOT's ROE is -0.22%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, MBOT is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check OSUR's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
MBOT vs INFU Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, INFU has a market cap of 247M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while INFU trades at $12.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas INFU's P/E ratio is 29.85. In terms of profitability, MBOT's ROE is -0.22%, compared to INFU's ROE of +0.15%. Regarding short-term risk, MBOT is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check INFU's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
MBOT vs UTMD Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, UTMD has a market cap of 226.1M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while UTMD trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas UTMD's P/E ratio is 21.01. In terms of profitability, MBOT's ROE is -0.22%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, MBOT is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
MBOT vs PDEX Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, PDEX has a market cap of 214M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while PDEX trades at $67.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas PDEX's P/E ratio is 23.60. In terms of profitability, MBOT's ROE is -0.22%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, MBOT is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
MBOT vs KRMD Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, KRMD has a market cap of 156.2M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while KRMD trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas KRMD's P/E ratio is -85.00. In terms of profitability, MBOT's ROE is -0.22%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, MBOT is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check KRMD's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
MBOT vs AKYA Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas AKYA's P/E ratio is -1.34. In terms of profitability, MBOT's ROE is -0.22%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, MBOT is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
MBOT vs DXR Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, DXR has a market cap of 60.7M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while DXR trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas DXR's P/E ratio is 27.20. In terms of profitability, MBOT's ROE is -0.22%, compared to DXR's ROE of +0.22%. Regarding short-term risk, MBOT is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
MBOT vs STSS Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas STSS's P/E ratio is -0.02. In terms of profitability, MBOT's ROE is -0.22%, compared to STSS's ROE of -1.54%. Regarding short-term risk, MBOT is more volatile compared to STSS. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
MBOT vs OMIC Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas OMIC's P/E ratio is -0.58. In terms of profitability, MBOT's ROE is -0.22%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, MBOT is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
MBOT vs IGAP Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas IGAP's P/E ratio is -10.52. In terms of profitability, MBOT's ROE is -0.22%, compared to IGAP's ROE of -0.86%. Regarding short-term risk, MBOT is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
MBOT vs NEPH Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, NEPH has a market cap of 50.2M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while NEPH trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas NEPH's P/E ratio is 77.08. In terms of profitability, MBOT's ROE is -0.22%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, MBOT is more volatile compared to NEPH. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
MBOT vs POCI Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, POCI has a market cap of 48M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while POCI trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas POCI's P/E ratio is -6.09. In terms of profitability, MBOT's ROE is -0.22%, compared to POCI's ROE of -0.37%. Regarding short-term risk, MBOT is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check POCI's competition here
Milestone Scientific Inc. (AMEX: MLSS)
MBOT vs MLSS Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, MLSS has a market cap of 43.8M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while MLSS trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas MLSS's P/E ratio is -8.25. In terms of profitability, MBOT's ROE is -0.22%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, MBOT is more volatile compared to MLSS. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check MLSS's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
MBOT vs HBIO Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, HBIO has a market cap of 30M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while HBIO trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas HBIO's P/E ratio is -18.49. In terms of profitability, MBOT's ROE is -0.22%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, MBOT is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check HBIO's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
MBOT vs SDC Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas SDC's P/E ratio is -0.03. In terms of profitability, MBOT's ROE is -0.22%, compared to SDC's ROE of -1.96%. Regarding short-term risk, MBOT is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check SDC's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
MBOT vs ZJYL Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ZJYL has a market cap of 26.5M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ZJYL trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ZJYL's P/E ratio is 21.13. In terms of profitability, MBOT's ROE is -0.22%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, MBOT is more volatile compared to ZJYL. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ZJYL's competition here
Invacare Corporation (NYSE: IVC)
MBOT vs IVC Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas IVC's P/E ratio is -0.79. In terms of profitability, MBOT's ROE is -0.22%, compared to IVC's ROE of -0.46%. Regarding short-term risk, MBOT is more volatile compared to IVC. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
MBOT vs RVP Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, RVP has a market cap of 20.7M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while RVP trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas RVP's P/E ratio is -2.10. In terms of profitability, MBOT's ROE is -0.22%, compared to RVP's ROE of -0.08%. Regarding short-term risk, MBOT is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check RVP's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
MBOT vs RGNT Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, RGNT has a market cap of 13.8M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while RGNT trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas RGNT's P/E ratio is -0.08. In terms of profitability, MBOT's ROE is -0.22%, compared to RGNT's ROE of N/A. Regarding short-term risk, MBOT is more volatile compared to RGNT. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check RGNT's competition here
Femasys Inc. (NASDAQ: FEMY)
MBOT vs FEMY Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, FEMY has a market cap of 6.9M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while FEMY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas FEMY's P/E ratio is -6.33. In terms of profitability, MBOT's ROE is -0.22%, compared to FEMY's ROE of -2.58%. Regarding short-term risk, MBOT is more volatile compared to FEMY. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check FEMY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
MBOT vs NSTG Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas NSTG's P/E ratio is -0.03. In terms of profitability, MBOT's ROE is -0.22%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, MBOT is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check NSTG's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
MBOT vs NXGL Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, NXGL has a market cap of 4.8M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while NXGL trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas NXGL's P/E ratio is -1.45. In terms of profitability, MBOT's ROE is -0.22%, compared to NXGL's ROE of -0.70%. Regarding short-term risk, MBOT is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check NXGL's competition here
Lucyd, Inc (NASDAQ: LUCY)
MBOT vs LUCY Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, LUCY has a market cap of 4.6M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while LUCY trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas LUCY's P/E ratio is -0.43. In terms of profitability, MBOT's ROE is -0.22%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, MBOT is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check LUCY's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
MBOT vs POAI Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas POAI's P/E ratio is -0.03. In terms of profitability, MBOT's ROE is -0.22%, compared to POAI's ROE of -107.05%. Regarding short-term risk, MBOT is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check POAI's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
MBOT vs GCTK Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, GCTK has a market cap of 2.8M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while GCTK trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas GCTK's P/E ratio is -0.02. In terms of profitability, MBOT's ROE is -0.22%, compared to GCTK's ROE of -5.82%. Regarding short-term risk, MBOT is more volatile compared to GCTK. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check GCTK's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
MBOT vs MHUA Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas MHUA's P/E ratio is 0.25. In terms of profitability, MBOT's ROE is -0.22%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, MBOT is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
MBOT vs GMVD Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas GMVD's P/E ratio is -0.01. In terms of profitability, MBOT's ROE is -0.22%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, MBOT is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
MBOT vs GMVDW Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas GMVDW's P/E ratio is N/A. In terms of profitability, MBOT's ROE is -0.22%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, MBOT is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
MBOT vs AVGR Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas AVGR's P/E ratio is -0.05. In terms of profitability, MBOT's ROE is -0.22%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, MBOT is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
MBOT vs NXGLW Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, NXGLW has a market cap of 1.2M. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas NXGLW's P/E ratio is -0.04. In terms of profitability, MBOT's ROE is -0.22%, compared to NXGLW's ROE of -0.70%. Regarding short-term risk, MBOT is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
MBOT vs LUCYW Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas LUCYW's P/E ratio is N/A. In terms of profitability, MBOT's ROE is -0.22%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, MBOT is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for MBOT.Check LUCYW's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
MBOT vs ATRS Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ATRS's P/E ratio is 14.95. In terms of profitability, MBOT's ROE is -0.22%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, MBOT is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ATRS's competition here
Analogic Corporation (NASDAQ: ALOG)
MBOT vs ALOG Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas ALOG's P/E ratio is 40.93. In terms of profitability, MBOT's ROE is -0.22%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, MBOT is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check ALOG's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
MBOT vs HRC Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, HRC has a market cap of 0. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas HRC's P/E ratio is 41.92. In terms of profitability, MBOT's ROE is -0.22%, compared to HRC's ROE of +0.14%. Regarding short-term risk, MBOT is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check HRC's competition here
IntriCon Corporation (NASDAQ: IIN)
MBOT vs IIN Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, IIN has a market cap of 0. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas IIN's P/E ratio is 226.45. In terms of profitability, MBOT's ROE is -0.22%, compared to IIN's ROE of -0.00%. Regarding short-term risk, MBOT is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check IIN's competition here
Invuity, Inc. (NASDAQ: IVTY)
MBOT vs IVTY Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas IVTY's P/E ratio is -3.80. In terms of profitability, MBOT's ROE is -0.22%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, MBOT is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check IVTY's competition here
Apria, Inc. (NASDAQ: APR)
MBOT vs APR Comparison August 2026
Microbot Medical Inc. (NASDAQ: MBOT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MBOT stands at 70.6M. In comparison, APR has a market cap of 0. Regarding current trading prices, MBOT is priced at $1.55 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MBOT currently has a P/E ratio of -5.96, whereas APR's P/E ratio is 22.59. In terms of profitability, MBOT's ROE is -0.22%, compared to APR's ROE of +9.81%. Regarding short-term risk, MBOT is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for MBOT.Check APR's competition here